Loading
Latest filing published 06 Mar 2023 for Concert Pharmaceuticals, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Thomas G. Auchincloss in Concert Pharmaceuticals, Inc., where the filings describe the role as board member. The record holds 4 filings, for trades running from 10 June 2021 to 6 March 2023.
Every open-market trade on record is a purchase: 1 purchase worth €27k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants.
The newest entry dates from 6 March 2023: a transaction, in Concert Pharmaceuticals, Inc. The last insider purchase was made public on 6 June 2022, 1,595 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations